CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Sham Magnetic stimulationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04488068
NCT04488068N/ACompleted
CompareCT.gov

Feasibility Testing of Transpelvic Magnetic Stimulation as a Novel Intervention toImprove Urogenital Function in Prostate Cancer Survivors

VA Office of Research and Development·interventional·Posted Jul 27, 2020·Updated Jul 29, 2024

In Brief

A clinical study evaluating Sham Magnetic stimulation for Prostate Cancer and Erectile Dysfunction. Completed, enrolled 12 participants across 1 site.

Detailed Summary

After recruitment, 20 male patients will be assigned 1:1 to either age-matched control (G1: sham) or age-matched intervention (G2: pelvic magnetic stimulation; TPMS) groups using computer-generated process, and baseline parameters will be established. All patients will be instructed by the investigators to perform standard of care pelvic floor exercise for the duration of the study. In addition, G2 patients will receive TPMS, while G1 patients will undergo sham treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer, Erectile Dysfunction
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJul 27, 2020
Enrollment StartOct 1, 2020
Primary CompletionAug 11, 2022
Study CompletionSep 30, 2022
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.9 years ago

Interventions

Sham Magnetic stimulationprocedure

Sham Magnetic stimulation for comparison.